LekoskopLekoskop
UK · ES · FR · CS · IT · NL · CH · HR · PL

Medicine recalls, shortages and safety updates in the UK — May 2026

MHRA medicines recalls and defect notifications with batch numbers, Serious Shortage Protocols, new approvals and Drug Safety Update — updated daily, automatically. Last updated: 27 Sep 2026 13:39.

All Recalls and defects2 Serious shortages (SSP)2 New approvals1 Drug Safety Update1
clear

Sources: we track changes based on information published by the MHRA — medicines recalls and defect notifications, Drug Safety Update and approval announcements — and the Serious Shortage Protocols published by the NHS Business Services Authority. The UK is outside the EU, so European Commission decisions are not listed here.

28 May 2026Thursday 28 May 2026

open day ◀ ▶ 1 event · 1 important
Medicines recall Ramipril 2.5 mg Capsules
Class 2 recall · DMRC - 39617807 · PL 20416/0295 · Crescent Pharma Limited. · ramipril
Batches: GR155023 (08/2027)
What this means, batches, details

Loading…

20 May 2026Wednesday 20 May 2026

open day ◀ ▶ 1 event · 1 important
Drug Safety Update Amiodarone
Amiodarone has been associated with serious and potentially life-threatening side effects, particularly of the lung, liver, and thyroid gland. We remind healthcare professionals that patients should b…
What this means, batches, details

Loading…

15 May 2026Friday 15 May 2026

open day ◀ ▶ 1 event
As with any medicine, the MHRA will keep the safety and effectiveness of Vyjuvek under close review.
What this means, batches, details

Loading…

14 May 2026Thursday 14 May 2026

open day ◀ ▶ 1 event
Class 4 defect notification · DMRC - 39439934 · PL: 13689/0013 · Fresenius Medical Care Deutschland GmbH · In 1 litre ready-to-use solution:
Batches: F4LM071 (11/2026), G4LB133 (01/2027), G4LL144 (10/2027), G4LM152 (11/2027), H4LB212 (11/2028), G4LI151 (08/2027)
What this means, batches, details

Loading…

11 May 2026Monday 11 May 2026

open day ◀ ▶ 2 events · 1 important
Drug Safety Update Finasteride and Dutasteride
The MHRA has reviewed the evidence for finasteride and dutasteride and the risk of suicidal thoughts and behaviours and has recommended further measures to minimise this risk.
What this means, batches, details

Loading…

Class 4 defect notification · DMRC - 39394163 · PL: 16363/0784 · Milpharm Limited · Loperamide hydrochloride
Batches: 25882X3 (30/11/2029), 25882X2 (30/11/2029)
What this means, batches, details

Loading…

In total 8 events this month.